Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-82,313
Closed -$337K 720
2023
Q1
$337K Sell
82,313
-35,135
-30% -$225K ﹤0.01% 846
2022
Q4
$989K Sell
117,448
-90,652
-44% -$630K 0.01% 698
2022
Q3
$1.27M Buy
+208,100
New +$871K 0.01% 663
2021
Q4
Sell
-93,204
Closed -$9.87M 800
2021
Q3
$9.87M Buy
93,204
+27,150
+41% +$2.43M 0.07% 273
2021
Q2
$7.21M Sell
66,054
-2,897
-4% -$289K 0.05% 334
2021
Q1
$9.27M Hold
68,951
0.08% 263
2020
Q4
$9.65M Sell
68,951
-42,921
-38% -$4.47M 0.08% 269
2020
Q3
$9.11M Hold
111,872
0.09% 255
2020
Q2
$8.04M Buy
111,872
+61,872
+124% +$4.15M 0.08% 251
2020
Q1
$4.66M Hold
50,000
0.05% 363
2019
Q4
$4.77M Buy
+50,000
New +$4.4M 0.05% 370

Other funds holding ALLK

Candriam SCA's ALLK Position: Q2 2023 in Review

Candriam SCA sold out of Allakos (ALLK) in Q2 2023, closing a stake of 82,313 shares — an estimated $337K sold.

Candriam SCA first reported a position in ALLK in Q4 2019 and held it in 11 quarters. The position peaked at $9.87M in Q3 2021. 131 funds tracked by Wall St. Rank hold ALLK as of Q2 2023.

  • Candriam SCA reported no remaining Allakos position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 82,313 Allakos shares in Q2 2023, an estimated $337K.
  • Candriam SCA first reported a position in Allakos in Q4 2019 and held it in 11 quarters.
  • Candriam SCA's Allakos position peaked at $9.87M in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Allakos as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.